China Pharma (NYSE:CPHI) Now Covered by

Stock analysts at began coverage on shares of China Pharma (NYSE:CPHIGet Rating) in a research report issued on Friday. The firm set a “hold” rating on the stock.

China Pharma Stock Down 6.7 %

CPHI opened at $0.32 on Friday. The firm has a market capitalization of $2.71 million, a P/E ratio of -0.40 and a beta of 0.49. China Pharma has a 1 year low of $0.29 and a 1 year high of $4.15.

About China Pharma

(Get Rating)

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm’s product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.

Featured Articles

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with's FREE daily email newsletter.